DBV Technologies S.A. (EPA:DBV)
2.285
-0.215 (-8.60%)
At close: Nov 28, 2025
DBV Technologies Employees
As of December 31, 2024, DBV Technologies had 110 total employees, including 109 full-time and 1 part-time employees. The number of employees increased by 5 or 4.76% compared to the previous year.
Employees
110
Change (1Y)
5
Growth (1Y)
4.76%
Revenue / Employee
€40,080
Profits / Employee
€911,546
Market Cap
410.54M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 110 | 5 | 4.76% |
| Dec 31, 2023 | 105 | 19 | 22.09% |
| Dec 31, 2022 | 86 | -6 | -6.52% |
| Dec 31, 2021 | 92 | -50 | -35.21% |
| Dec 31, 2020 | 142 | -169 | -54.34% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| EssilorLuxottica Société anonyme | 153,498 |
| emeis Société anonyme | 83,494 |
| Sanofi | 82,878 |
| Eurofins Scientific SE | 62,696 |
| Clariane SE | 61,798 |
| Ramsay Générale de Santé | 40,494 |
| bioMérieux | 14,754 |
| Sartorius Stedim Biotech | 9,901 |
DBV Technologies News
- 18 days ago - DBVT Completes Key Phase 3 Trial for Peanut Allergy Treatment - GuruFocus
- 18 days ago - DBV Technologies On Track To Report Data From VITESSE Phase 3 Trial Of VIASKIN Peanut Patch In Q4 - Nasdaq
- 19 days ago - DBV Technologies Announces Last Patient Visit Completed in VITESSE Phase 3 Clinical Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years - GlobeNewsWire
- 26 days ago - DBV Technologies to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference - GlobeNewsWire
- 27 days ago - DBV Technologies Appoints Industry Leader Kevin Trapp as Chief Commercial Officer - GlobeNewsWire
- 4 weeks ago - DBV Technologies Announces Appointment of Philina Lee, Ph.D. to Board of Directors - GlobeNewsWire
- 4 weeks ago - DBV Technologies to Participate in Upcoming ACAAI 2025 Annual Scientific Meeting - GlobeNewsWire
- 4 weeks ago - DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq - GlobeNewsWire